PR Newswire BiotechOriginal article
Molecular Devices and HeartBeat.bio Help Researchers Identify Cardiac Safety Risks Earlier with New Human Cardiac Organoid Solution
Positive
AI Analysis
Summary
Molecular Devices and HeartBeat.bio announced new 3D Ready Cardioid Supplement Kits combining cardiac organoid biology with automated workflows to help researchers generate reproducible cardiac models for drug discovery and safety assessment.
Importance:3/10
Sentiment:
0.60
product launchcardiac safetydrug discovery3D organoidscollaboration
Related Companies
Read the original article
Published by PR Newswire Biotech on August 10, 2026 12:05 PM
